10 /100
LOW RISK
Score updated Jul 13, 2026

NICE — NICE Ltd. Dilution Risk Tracker

Track NICE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NICE — Get alerts when the score changes →

As of July 13, 2026, NICE Ltd. (NICE) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. NICE Ltd. has a market capitalization of $5.43B, 60.43M shares outstanding, 10 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
19
💰 Cash Runway
0
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NICE.
🔔 Track NICE — Get forecast alerts →

💹 Market Data

Market Cap$5.43B
Shares Outstanding60.43M
Float59.50M
Cash$417.40M
Debt$86.08M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 18.17M shares
#1 Principal Financial Group, Inc. 4.58M shares
#2 Harding Loevner LP 2.58M shares
#3 Menora Mivtachim Holdings Ltd. 1.86M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest2.82M
Days to Cover4.4
% of Float4.7%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2022
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NICE Shareholders

NICE Ltd. (NICE) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for NICE shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for NICE in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NICE alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NICE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NICE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NICE
📊 NICE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NICE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.